Clinical Updates
Launch of Generic Entresto (sacubitril/valsartan) Tablets
Generic Entresto (sacubitril/valsartan) has recently been approved by the FDA and released in 24mg/26mg, 49mg/51mg…
Nevada Adopts ODG Drug Formulary
Bipartisan legislation makes Nevada the thirteenth state to adopt an ODG tool for workers’ comp…
Launch of Brilinta® (Ticagrelor) Tablets
Generic Brilinta® (Ticagrelor) has been approved by the FDA. Ticagrelor tablets are indicated to reduce…
The Carlisle Drug Reference Guide
This guide provides a list of frequently prescribed medications by brand name, their generic…
Launch of Generic Xarelto (Rivaroxaban) Tablets
Generic Xarelto (Rivaroxaban) has recently been approved by the FDA and released in 2.5 mg…
Introducing Journavx™: A New Non-Opioid Pain Relief Medication
Vertex Pharmaceuticals has introduced Journavx™ (suzetrigine)—a non-opioid medication for moderate-to-severe acute pain in adults. Unlike opioids,…
The Carlisle Drug Reference Guide
This guide provides a list of frequently prescribed medications by brand name, their generic…
Launch of generic Motegrity (Prucalopride) tablets
Generic Motegrity (Prucalopride) has recently been released and is approved by the FDA. Prucalopride…
Anticipated Generic Releases 2025
There are several brand name medications that will lose exclusivity in the first half of…
LSU Health New Orleans Announces Non-additive, Non-Toxic Painkiller
LSU Health New Orleans announces the discovery and clinical development of a new non-opioid therapeutic…
